Donor-Recipient ABO Compatibility Independently Influences Survival after Allogeneic HSCT: Outcomes of 281 Patients from a Single Centre Duncan Purtill, MBBS, FRACP, FRCPA, Marian Sturm, PhD, Anastasia Keegan, MBBS, FRACP, FRCPA, Megan Margaria, CN Bsc (Nursing), Susan Buffery, RN, Annette Le Viellez, Paul Chiappini, Julian P. Cooney, MBBS FRACP FRCPA, Paul Cannell, MBBS FRCPA FRACP, Matthew Wright, MBBS FRACP FRCPA Biology of Blood and Marrow Transplantation Volume 22, Issue 3, Pages S348-S349 (March 2016) DOI: 10.1016/j.bbmt.2015.11.842 Copyright © 2016 Terms and Conditions
Figure Overall Survival According to Donor — Recipient ABO Compatibility Biology of Blood and Marrow Transplantation 2016 22, S348-S349DOI: (10.1016/j.bbmt.2015.11.842) Copyright © 2016 Terms and Conditions